Leveraging Social Determinants of Health to Enhance Recruitment of Underrepresented Populations in Clinical Trials

Sara King; Sophia Trabanino; Zahra Azizi; Fatima Rodriguez

doi:10.14797/mdcvj.1447

Leveraging Social Determinants of Health to Enhance Recruitment of Underrepresented Populations in Clinical Trials

Methodist DeBakey Cardiovascular Journal

Volume 20 (2024): Issue 5

By: Sara King , Sophia Trabanino, Zahra Azizi and Fatima Rodriguez

Open Access

|Nov 2024

Abstract

Historically marginalized communities are disproportionately affected by cardiometabolic diseases yet are underrepresented in clinical trials that investigate needed interventions. This review investigates the barriers to equitable inclusion in clinical trials, identifying opportunities for improvement at the institutional, trial, community, and individual level. It proposes a social determinants-based approach that serves as a toolkit to target these barriers using structural, economic, community, healthcare access, and technology solutions, supporting constructive improvement in the clinical trial recruitment process.

References

National Institutes of Health (Internet). Bethesda, MD: National Institutes of Health; c2024. NIH’s Definition of a Clinical Trial; updated 2024 June 10 [cited 2024 Jun 15]. Available from: https://grants.nih.gov/policy/clinical-trials/definition.htm
Search in Google Scholar Back to article
Kelsey MD, Patrick-Lake B, Abdulai R, et al. Inclusion and diversity in clinical trials: Actionable steps to drive lasting change. Contemp Clin Trials. 2022 May;116:106740. doi: 10.1016/j.cct.2022.106740
Open DOI Search in Google Scholar Back to article
U.S. Food and Drug Administration [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; c2024. Drug Trials Snapshots Summary Report; 2023; 2024 [cited 2024 Jun 1]. Available from: https://www.fda.gov/media/178602/download?attachment
Search in Google Scholar Back to article
U.S. Census [Internet]. Washington, DC: U.S. Department of Commerce; c2024. Jensen E, Jones N, Rabe M, et al. 2020 U.S. population more racially and ethnically diverse than measured in 2010; updated 2023 Oct 11 [cited 2024 Jun 1]. Available from: https://www.census.gov/library/stories/2021/08/2020-united-states-population-more-racially-ethnically-diverse-than-2010.html
Search in Google Scholar Back to article
Buffenstein I, Kaneakua B, Taylor E, et al. Demographic recruitment bias of adults in United States randomized clinical trials by disease categories between 2008 to 2019: A systematic review and meta-analysis. Sci Rep. 2023 Jan;13:42. doi: 10.1038/s41598-022-23664-1
Open DOI Search in Google Scholar Back to article
DeCormier Plosky W, Ne’eman A, Silverman BC, et al. Excluding people with disabilities from clinical research: Eligibility criteria lack clarity and justification. Health Aff (Millwood). 2022 Oct;41(10):1423-1432. doi: 10.1377/hlthaff.2022.00520
Open DOI Search in Google Scholar Back to article
Sardar MR, Badri M, Prince CT, Seltzer J, Kowey PR. Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. JAMA Intern Med. 2014 Nov;174(11):1868-70. doi: 10.1001/jamainternmed.2014.4758
Open DOI Search in Google Scholar Back to article
Sarraju A, Valencia A, Knowles JW, Maron DJ, Rodriguez F. Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials. Circulation. 2021 Jun 15;143(24):2409-2411. doi: 10.1161/CIRCULATIONAHA.120.050034
Open DOI Search in Google Scholar Back to article
National Academies [Internet]. Washington, DC: National Academies Press; c2024. National Academies of Sciences, Engineering, and Medicine. Bibbins-Domingo K, Helman A, editors. Improving representation in clinical trials and research: building research equity for women and underrepresented groups; 2022 [cited 2024 Sep 4]. Available from: https://nap.nationalacademies.org/catalog/26479/improving-representation-in-clinical-trials-and-research-building-research-equity
Search in Google Scholar Back to article
Bodicoat DH, Routen AC, Willis A, et al. Promoting inclusion in clinical trials-a rapid review of the literature and recommendations for action. Trials. 2021 Dec 4;22(1):880. doi: 10.1186/s13063-021-05849-7
Open DOI Search in Google Scholar Back to article
Ehrhardt S, Appel LJ, Meinert CL. Trends in National Institutes of Health Funding for Clinical Trials Registered in ClinicalTrials.gov. JAMA. 2015 Dec 15;314(23):2566-7. doi: 10.1001/jama.2015.12206
Open DOI Search in Google Scholar Back to article
Turner BE, Steinberg JR, Weeks BT, Rodriguez F, Cullen MR. Race/ethnicity reporting and representation in US clinical trials: a cohort study. Lancet Reg Health Am. 2022 Jul;11:100252. doi: 10.1016/j.lana.2022.100252
Open DOI Search in Google Scholar Back to article
Unger JM, Hershman DL, Osarogiagbon RU, et al. Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies. JNCI Cancer Spectr. 2020 Apr 24;4(4):pkaa034. doi: 10.1093/jncics/pkaa034
Open DOI Search in Google Scholar Back to article
Xiao H, Vaidya R, Liu F, Chang X, Xia X, Unger JM. Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023 Jan 1;183(1):50-60. doi: 10.1001/jamainternmed.2022.5600
Open DOI Search in Google Scholar Back to article
McDonald KE, Schwartz AE, Sabatello M. Eligibility criteria in NIH-funded clinical trials: Can adults with intellectual disability get in? Disabil Health J. 2022 Oct;15(4):101368. doi: 10.1016/j.dhjo.2022.101368
Open DOI Search in Google Scholar Back to article
Kanapuru B, Fernandes LL, Baines A, et al. Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials. Blood. 2023 Jul 20;142(3):235-243. doi: 10.1182/blood.2022018657
Open DOI Search in Google Scholar Back to article
Webb Hooper M, Asfar T, Unrod M, et al. Reasons for Exclusion from a Smoking Cessation Trial: An Analysis by Race/Ethnicity. Ethn Dis. 2019 Jan 17;29(1):23-30. doi: 10.18865/ed.29.1.23
Open DOI Search in Google Scholar Back to article
Guadagnolo BA, Petereit DG, Helbig P, et al. Involving American Indians and medically underserved rural populations in cancer clinical trials. Clin Trials. 2009 Dec;6(6):610-7. doi: 10.1177/1740774509348526
Open DOI Search in Google Scholar Back to article
Riner AN, Girma S, Vudatha V, et al. Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials. J Clin Oncol. 2022 Jul 10;40(20):2193-2202. doi: 10.1200/JCO.21.02492
Open DOI Search in Google Scholar Back to article
Defilippis EM, Echols M, Adamson PB, et al. Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory. JAMA Cardiol. 2022 May 1;7(5):540-548. doi: 10.1001/jamacardio.2022.0161
Open DOI Search in Google Scholar Back to article
Gupta DK, de Lemos JA, Ayers CR, Berry JD, Wang TJ. Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study. JACC Heart Fail. 2015 Jul;3(7):513-519. doi: 10.1016/j.jchf.2015.02.008
Open DOI Search in Google Scholar Back to article
Seidler EM, Keshaviah A, Brown C, Wood E, Granick L, Kimball AB. Geographic distribution of clinical trials may lead to inequities in access. Clin Invest. 2014;4:373-380. doi: 10.4155/cli.14.21
Open DOI Search in Google Scholar Back to article
Galsky MD, Stensland KD, McBride RB, et al. Geographic accessibility to clinical trials for advanced cancer in the United States. JAMA Intern Med. 2015 Feb;175(2):293-5. doi: 10.1001/jamainternmed.2014.6300
Open DOI Search in Google Scholar Back to article
Agency for Healthcare Research & Quality [Internet]. Rockville, MD: US Department of Health and Human Services; c2024. National Healthcare Quality & Disparities Report; reviewed 2015 Jun [cited 2024 Sep 4]. Available from: http://www.ahrq.gov/research/findings/nhqrdr/nhqdr14/key1.html
Search in Google Scholar Back to article
Tikkanen RS, Woolhandler S, Himmelstein DU, et al. Hospital Payer and Racial/Ethnic Mix at Private Academic Medical Centers in Boston and New York City. Int J Health Serv. 2017 Jul;47(3):460-476. doi: 10.1177/0020731416689549
Open DOI Search in Google Scholar Back to article
Occa A, Morgan SE, Potter JE. Underrepresentation of Hispanics and Other Minorities in Clinical Trials: Recruiters’ Perspectives. J Racial Ethn Health Disparities. 2018 Apr;5(2):322-332. doi: 10.1007/s40615-017-0373-x
Open DOI Search in Google Scholar Back to article
Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol. 2000 Nov;10(8 Suppl):S22-34. doi: 10.1016/s1047-2797(00)00195-2
Open DOI Search in Google Scholar Back to article
Versavel S, Subasinghe A, Johnson K, et al. Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsor. Contemp Clin Trials. 2023 Mar;126:107092. doi: 10.1016/j.cct.2023.107092
Open DOI Search in Google Scholar Back to article
BiopharmaDive [Internet]. Washington, DC: BiopharmaDive; c2024. Dunn A, Pagliarulo N. Follow the money: how biopharma CEOs and workers got paid in 2018; 2019 May 28 [cited 10 June 2024]. Available from https://www.biopharmadive.com/news/biotech-pharma-ceo-employee-pay/554283/
Search in Google Scholar Back to article
Getz K, Faden L. Racial disparities among clinical research investigators. Am J Ther. 2008 Jan-Feb;15(1):3-11. doi: 10.1097/MJT.0b013e31815fa75a
Open DOI Search in Google Scholar Back to article
Reza N, Tahhan AS, Mahmud N. Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials. Circ Heart Fail. 2020 Aug;13(8):e006605. doi: 10.1161/CIRCHEARTFAILURE.119.006605
Open DOI Search in Google Scholar Back to article
Yong C, Suvarna A, Harrington R, et al. Temporal Trends in Gender of Principal Investigators and Patients in Cardiovascular Clinical Trials. J Am Coll Cardiol. 2023 Jan 31;81(4):428-430. doi: 10.1016/j.jacc.2022.10.038
Open DOI Search in Google Scholar Back to article
Clark LT, Watkins L, Piña IL, et al. Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Curr Probl Cardiol. 2019 May;44(5):148-172. doi: 10.1016/j.cpcardiol.2018.11.002
Open DOI Search in Google Scholar Back to article
Millar MM, Taft T, Weir CR. Clinical trial recruitment in primary care: exploratory factor analysis of a questionnaire to measure barriers and facilitators to primary care providers’ involvement. BMC Prim Care. 2022 Dec 3;23(1):311. doi: 10.1186/s12875-022-01898-2
Open DOI Search in Google Scholar Back to article
Katz RV, Kegeles SS, Kressin NR, et al. Awareness of the Tuskegee Syphilis Study and the US presidential apology and their influence on minority participation in biomedical research. Am J Public Health. 2008 Jun;98(6):1137-42. doi: 10.2105/AJPH.2006.100131
Open DOI Search in Google Scholar Back to article
Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006 Feb;3(2):e19. doi: 10.1371/journal.pmed.0030019
Open DOI Search in Google Scholar Back to article
U.S. Department of Labor [Internet]. Washington, DC: U.S. Department of Labor; c2024. Earnings and Ratios: Women’s Bureau; 2024 [cited 2024 Sep 4]. Available from: https://www.dol.gov/agencies/wb/data/earnings
Search in Google Scholar Back to article
Kaiser Family Foundation [Internet]. San Francisco, CA: Kaiser Family Foundation; c2024. Drake P, Burns A. Working-age adults with disabilities living in the community; 2024 Jan 4 [cited 2024 Sep 4]. Available from: https://www.kff.org/medicaid/issue-brief/working-age-adults-with-disabilities-living-in-the-community/
Search in Google Scholar Back to article
Goodman JM, Richardson DM, Dow WH. Racial and Ethnic Inequities in Paid Family and Medical Leave: United States, 2011 and 2017–2018. Am J Public Health. 2022 Jul;112(7):1050-1058. doi: 10.2105/AJPH.2022.306825
Open DOI Search in Google Scholar Back to article
Bonevski B, Randell M, Paul C, et al. Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med Res Methodol. 2014 Mar 25;14:42. doi: 10.1186/1471-2288-14-42
Open DOI Search in Google Scholar Back to article
Friedman SH, Cunningham CO, Lin J, Haramati LB, Levsky JM. Having a Primary Care Provider is the Strongest Predictor of Successful Follow-up of Participants in a Clinical Trial. J Am Board Fam Med. 2020 May-Jun;33(3):431-439. doi: 10.3122/jabfm.2020.03.190018
Open DOI Search in Google Scholar Back to article
Gadegbeku CA, Stillman PK, Huffman MD, Jackson JS, Kusek JW, Jamerson KA. Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension. Contemp Clin Trials. 2008 Nov;29(6):837-42. doi: 10.1016/j.cct.2008.06.001
Open DOI Search in Google Scholar Back to article
U.S. Food & Drug Administration [Internet]. Silver Spring, MD: U.S. Food & Drug Administration; c2024. Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials; draft guidance for industry; 2022 Apr [cited 2024 Sep 4]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-plans-improve-enrollment-participants-underrepresented-racial-and-ethnic-populations
Search in Google Scholar Back to article
National Institute of Health (Internet). Bethesda, MD: National Institute of Health; c2024. Diversity related funding opportunity announcements; 2024 [cited 2024 Sep 4]. Available from: https://extramural-diversity.nih.gov/guidedata/data
Search in Google Scholar Back to article
Pfizer [Internet]. New York, NY: Pfizer; c2024. Covington. A report to Pfizer Inc. on its efforts to promote racial equity, diversity, and inclusion; 2024 May [cited 2024 Sep 4]. Available from: https://cdn.pfizer.com/pfizercom/Pfizer_Racial_Equity_Assessment_Report_031424.pdf
Search in Google Scholar Back to article
Largent EA, Fernandez Lynch H. Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward. Yale J Health Policy Law Ethics. 2017 Winter;17(1):61-141. PMID: 29249912
Search in Google Scholar Back to article
Las Nueces D, Hacker K, Digirolamo A, Hicks LS. A systematic review of community-based participatory research to enhance clinical trials in racial and ethnic minority groups. Health Serv Res. 2012 Jun;47(3 Pt 2):1363-86. doi: 10.1111/j.1475-6773.2012.01386.x
Open DOI Search in Google Scholar Back to article
Crocker JC, Ricci-Cabello I, Parker A, et al. Impact of patient and public involvement on enrolment and retention in clinical trials: Systematic review and meta-analysis. BMJ. 2018 Nov 28;363:k4738. doi: 10.1136/bmj.k4738
Open DOI Search in Google Scholar Back to article
Centers for Disease Control and Prevention [Internet]. Atlanta, GA: Center for Disease Control and Prevention; c2024. Principles of Community Engagement. 2nd ed; 2011 Jun [cited 2024 Sep 4]. Available from: https://www.atsdr.cdc.gov/communityengagement/index.html
Search in Google Scholar Back to article
Haynes N, Kaur A, Swain J, Joseph JJ, Brewer LC. Community-Based Participatory Research to Improve Cardiovascular Health Among US Racial and Ethnic Minority Groups. Curr Epidemiol Rep. 2022;9(3):212-221. doi: 10.1007/s40471-022-00298-5
Open DOI Search in Google Scholar Back to article
Spertus JA, Birmingham MC, Nassif M, et al. The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial. Nat Med. 2022 Apr;28(4):809-813. doi: 10.1038/s41591-022-01703-8
Open DOI Search in Google Scholar Back to article
Sarraju A, Seninger C, Parameswaran V, et al. Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP). NPJ Digit Med. 2022 Jun 28;5(1):80. doi: 10.1038/s41746-022-00622-9
Open DOI Search in Google Scholar Back to article
Kasahara A, Mitchell J, Yang J, Cuomo RE, McMann TJ, Mackey TK. Digital technologies used in clinical trial recruitment and enrollment including application to trial diversity and inclusion: A systematic review. Digit Health. 2024 Mar 28;10:20552076241242390. doi: 10.1177/20552076241242390
Open DOI Search in Google Scholar Back to article
Broadwin C, Azizi Z, Rodriguez F. Clinical Trial Technologies for Improving Equity and Inclusion in Cardiovascular Clinical Research. Cardiol Ther. 2023 Jun;12(2):215-225. doi: 10.1007/s40119-023-00311-y
Open DOI Search in Google Scholar Back to article
Blood AJ, Cannon CP, Gordon WJ, et al. Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network. JAMA Cardiol. 2023 Jan 1;8(1):12-21. doi: 10.1001/jamacardio.2022.4018. Erratum in: JAMA Cardiol. 2023 Jan 1;8(1):100. doi: 10.1001/jamacardio.2022.4695
Open DOI Search in Google Scholar Back to article
Brewer LC, Jenkins S, Hayes SN, et al. Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial. Am Heart J. 2022 May;247:1-14. doi: 10.1016/j.ahj.2022.01.009
Open DOI Search in Google Scholar Back to article
Harrer S, Shah P, Antony B, Hu J. Artificial Intelligence for Clinical Trial Design. Trends Pharmacol Sci. 2019 Aug;40(8):577-591. doi: 10.1016/j.tips.2019.05.005
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1447 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 81 - 88

Submitted on: Jul 11, 2024

Accepted on: Jul 22, 2024

Published on: Nov 5, 2024

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

© 2024 Sara King, Sophia Trabanino, Zahra Azizi, Fatima Rodriguez, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 20 (2024): Issue 5